FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
HealthcareSpeculativeSmall CapMomentum Trap
- £179.06m
- £184.52m
RCS - Faron Pharma. Oy - Bexmarilimab KOL Event
AnnouncementRCS - Faron Pharma. Oy - Poster Presentations at AACR 2023
AnnouncementREG - Faron Pharma. Oy - BEXMAB study update
AnnouncementRCS - Faron Pharma. Oy - Faron at Canaccord Oncology Virtual Conference
AnnouncementREG - Faron Pharma. Oy - Appointment of Chief Financial Officer
AnnouncementREG - Faron Pharma. Oy - Board Change
AnnouncementREG - Faron Pharma. Oy - Results of AGM
AnnouncementREG - Faron Pharma. Oy - Positive FDA Feedback to Progress Bexmarilimab
AnnouncementREG - Faron Pharma. Oy - Notice of Faron Pharmaceuticals Ltd’s AGM
AnnouncementREG - Faron Pharma. Oy - Faron´s Annual Report 2022 Published
AnnouncementREG - Faron Pharma. Oy - Financial Statement January 1 to December 31 2022
AnnouncementREG - Faron Pharma. Oy - Update to Faron’s Financial Calendar for 2023
AnnouncementRCS - Faron Pharma. Oy - Notice of 2022 Full-Year Results and Annual Report
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 31/01/2023
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - Faron Pharma. Oy - Results of Placing
AnnouncementREG - Faron Pharma. Oy - Proposed Issue and Placing
AnnouncementREG - Faron Pharma. Oy - Price Monitoring Extension
Announcement